Vir Biotechnology, Inc. - Vir Biotechnology Announces New …
https://investors.vir.bio/news/news-details/2022/Vir-Biotechnology-Announces-New-Clinical-Data-From-its-Broad-Hepatitis-B-Program-06-25-2022/default.aspx
WebSAN FRANCISCO, June 25, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today announced new data from its robust hepatitis B virus (HBV) clinical trial program, including results from an ongoing Phase 2 clinical trial of VIR-2218, results from an ongoing Phase 1 clinical trial of VIR-3434 and preclinical data evaluating both inves...
DA: 43 PA: 42 MOZ Rank: 9